Pabalinas, Jhon Andrei .
HRN: 26-95-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/14/2025
04/20/2025
IV DRIP
1.8g
Q8
PCAP-C & Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes